Executive and Operational Management

Vincent Capponi Chief Operating Officer Mr. Capponi has more than 20 years of management experience in medical device, pharmaceutical and imaging equipment at companies including Upjohn, Sims Deltec and Sabratek. Mr. Capponi joined MedaSorbCorp as our VP of Operations in 2002 until his recent promotion to Chief Operating Officer in 2005. Prior to joining MedaSorb Technologies Corporation, he held several senior management positions at Sabratek and its diagnostics division GDS. Mr. Capponi was interim president of GDS diagnostics in 2001, and from 2000 to 2001 he was responsible for the integration of the Baxter-Sabratek acquisition. From 1998 to 2000 Mr. Capponi was Senior VP and COO for Sabratek and VP Operations from 1996 to 1998. Mr. Capponi has extensive experience in process scale-up and high volume medical disposables production. He received his MS in Chemistry and his BS in Chemistry and Microbiology from Bowling Green State University.

David Lamadrid, MBA Chief Financial Officer Mr. Lamadrid has primary responsibility for managing MedaSorb Corp’s finance department. His responsibilities include managing all areas of financial management and planning, accounting functions, and the Company’s information systems. He has 15 years of business experience in finance and management. Prior to joining MedaSorb in 2000, Mr. Lamadrid was a financial analyst at Chase Manhattan Bank working in the Middle Market Division. He also has experience in high growth product distribution companies. Mr. Lamadrid earned his AAS in Accounting from S.U.N.Y. Rockland, a BS in Finance from St. John’s University, and an MBA from New York University.

Robert Bartlett, M.D. Chief Medical Officer Bartlett is Professor Emeritus of Surgery at the University of Michigan Health System. Prior to becoming Professor Emeritus in 2005, Dr. Bartlett was Director of the Surgical Intensive Care Unit, Chief of the Trauma/Critical Care division and Director of the Extracorporeal Life Support Program at the University of Michigan Medical Center. Dr. Bartlett was the pioneer in the development of the extracorporeal membrane oxygenation machine (ECMO), used to oxygenate blood in critically ill patients worldwide. He received his MD from the University of Michigan Medical School, cum laude. He completed his general surgery residency at Peter Bent Brigham Hospital in Boston, and was Chief resident in thoracic surgery. Dr. Bartlett was also a NIH Trainee in Academic Surgery at Harvard Medical School, and was previously faculty at the University of California, Irvine. Dr. Bartlett is the recipient of 26 separate research grants, 14 from the National Institutes of Health, including an RO1 grant for the development of a totally artificial lung. He has also received numerous national and international awards for his contributions to critical care medicine. Dr. Bartlett brings a wealth of research and clinical experience including management of sepsis, acute respiratory distress syndrome, and mechanical life support systems and continues to be active in lab and clinical research.